Register Login

VIRIDIAN THERAPEUTICS, INC.\DE (VRDN)

SymbolVRDN
NameVIRIDIAN THERAPEUTICS, INC.\DE
SectorHEALTH CARE
RegionNorth America
IndustryPharmaceutical Preparations
Address221 CRESCENT STREET, WALTHAM, MA 02453
Telephone617.272.4600
Fax—
Email—
Websitehttps://www.viridiantherapeutics.com
IncorporationUNDEFINED
Incorporated On—
Employees—
Fiscal Year—
Public Since—
ExchangesNASDAQ
Auditor—
Audit StatusNOT PROVIDED
Reporting Status—
CIK0001590750
Description

Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate VRDN-001 is an insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody (mAb) being developed for the potential treatment for patients with thyroid eye disease.

Additional info from NASDAQ:
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate VRDN-001 is an insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody (mAb) being developed for the potential treatment for patients with thyroid eye disease.

2026-08-21 00:05

Tousignant Jennifer 🟡 adjusted position in 14.2K shares (1 derivative) of Viridian Therapeutics, Inc.\DE (VRDN) at $24.50 Transaction Date: Aug 19, 2026 | Filing ID: 359636

Read more
2026-08-20 17:15

New Form SCHEDULE 13G - Viridian Therapeutics, Inc.\DE <b>Filed:</b> 2026-08-20 <b>AccNo:</b> 0000919574-26-005637 <b>Size:</b> 17 KB

Read more
2026-08-19 18:30

📋 Tousignant Jennifer (Officer) plans to sell 14K shares of Viridian Therapeutics, Inc.\DE (at $24.50 each, total $348K) Filed: Aug 19, 2026 | ID: 006222

Read more
2026-08-18 21:34

Tripuraneni Radhika 🟡 adjusted position in 0 shares (1 derivative) of Viridian Therapeutics, Inc.\DE (VRDN) at $13.21 ($1.1M) Transaction Date: Aug 14, 2026 | Filing ID: 355735

Read more
2026-08-14 17:29

New Form SCHEDULE 13G/A - Viridian Therapeutics, Inc.\DE <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001104659-26-097208 <b>Size:</b> 12 KB

Read more
2026-08-14 13:22

New Form SCHEDULE 13G/A - Viridian Therapeutics, Inc.\DE <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001907884-26-000016 <b>Size:</b> 9 KB

Read more
2026-08-14 09:33

New Form SCHEDULE 13G/A - Viridian Therapeutics, Inc.\DE <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001172661-26-003486 <b>Size:</b> 11 KB

Read more
2026-08-07 12:13

New Form SCHEDULE 13G - Viridian Therapeutics, Inc.\DE <b>Filed:</b> 2026-08-07 <b>AccNo:</b> 0000093751-26-000558 <b>Size:</b> 8 KB

Read more
2026-08-06 11:01

Viridian Therapeutics, Inc. - Viridian Therapeutics Highlights Recent Business Progress and Reports Second Quarter 2026 Financial Results

Read more
2026-08-06 11:01

Viridian Therapeutics Highlights Recent Business Progress and Reports Second Quarter 2026 Financial Results

Read more